| 000 | 01225 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250512082243.0 | ||
| 264 | 0 | _c19850401 | |
| 008 | 198504s 0 0 eng d | ||
| 022 | _a0344-5704 | ||
| 024 | 7 |
_a10.1007/BF00434351 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChang, B K | |
| 245 | 0 | 0 |
_aComparison of the cellular pharmacology of doxorubicin in resistant and sensitive models of pancreatic cancer. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _c1985 |
||
| 300 |
_a132-4 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Count |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aDoxorubicin _xmetabolism |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xmetabolism |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aGregory, J A | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 14 _gno. 2 _gp. 132-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00434351 _zAvailable from publisher's website |
| 999 |
_c3977161 _d3977161 |
||